Isotonic Sodium Chloride is one of 150 small molecule programs targeting Orthostatic Intolerance. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
583 competitors in Schizophrenia
Isotonic Sodium Chloride
Celexa
Ozempic
Resotran
Zocor
Comtan
Persantine
Permax
Luvox
Catapres
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources